XIGDUO
Film-coated tablet, 850mg + 5mg
RxActive license
Active substance (INN)
dapagliflozinmetformin
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength850mg + 5mg
PackagingUkupno 56 film tableta u blisteru (4x14) u kartonskoj kutiji
ManufacturerAstraZeneca GmbH, Germany
Therapeutic groupAlimentary tract and metabolism (A10BD15)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateMarch 2, 2021
Analogs in Montenegro
20Other medicines with the same active substance
CRITEO DUORx
Film-coated tablet, 50mg + 1000mgCRITEO DUORx
Film-coated tablet, 50mg + 850mgDAGRADUORx
Film-coated tablet, 100mg/10mgDAGRAFORSRx
Film-coated tablet, 10mgDAGRAFORSRx
Film-coated tablet, 5mgDOLISTA DUORx
Film-coated tablet, 850mg + 50mgDOLISTA DUORx
Film-coated tablet, 1000mg + 50mgEPROCLIVRx
Film-coated tablet, 1000mg + 50mgEPROCLIVRx
Film-coated tablet, 1000mg + 50mgEUCREASRx
Film-coated tablet, 50mg + 1000mgFORDEX®Rx
Film-coated tablet, 1000mgFORXIGARx
Film-coated tablet, 10mgFORXIGARx
Film-coated tablet, 5mgGLUCOPHAGERx
Film-coated tablet, 1000mgGLUCOPHAGERx
Film-coated tablet, 1000mgGLUCOPHAGERx
Film-coated tablet, 500mgGLUCOPHAGERx
Film-coated tablet, 500mgGLUCOPHAGERx
Film-coated tablet, 850mgGLUCOPHAGE XRRx
Prolonged-release tablet, 750mgGLUCOPHAGE XRRx
Prolonged-release tablet, 1000mgSource: CInMED register